Oncology Account Manager, North Central
Launched Avutometinib and Defactinib in LGSOC; drives sales with strategic collaboration and deep oncology knowledge.
Remote • Minneapolis, MN, USA
- Full Time
- $180,000 – $215,000/year
- Min. 5 YOE
Browse the full live job inventory for Verastem Oncology. This page is focused on current openings, while the overview tab highlights role groups and hiring patterns.
Launched Avutometinib and Defactinib in LGSOC; drives sales with strategic collaboration and deep oncology knowledge.
Field-based medical/scientific expert engaging with providers on investigational products and fostering research collaborations across oncology portfolio.
Oversees global phase 3 clinical trial operations, leadership of cross-functional team, and regulatory compliance.
Medical science liaison with field-based engagement across oncology, leading education, collaboration, and research opportunities.
Executive leadership for clinical development programs in oncology, leading study execution and regulatory strategy.
Lead DS development, scale-up, and tech transfer with external CMOs for clinical and potential commercial drug substances.
Assists Regulatory Leadership with the development and implementation of Regulatory strategy for timely development of investigational products and guide and assist in preparation of domestic and international registration dossiers.
The analytical engine of the commercial organization responsible for forecasting, analytics, and decision-ready outputs to drive portfolio performance.
Owns the operational backbone enabling the commercial field to perform; full-stack field operations across strategy, systems, analytics, and execution.
Assists clinical operations team to facilitate execution of trial processes per regulatory guidelines and ICH/GCP standards.
Analyses safety data and signals to support drug safety operations and regulatory compliance.
Lead SAS programming for CDISC-compliant ADaM/SDTM datasets, tables, listings, and figures for regulatory submissions.
Senior-level role managing global Phase 3 clinical trials, vendor management, and regulatory compliance.
Lead oncology sales strategy, launches of Avutometinib/Defactinib in LGSOC with cross-functional collaboration.